Multiple Myeloma in Relapse Completed Phase 1 Trials for Pomalidomide (DB08910)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02103335Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple MyelomaTreatment